About Maddie BioGenetics

MaddieBio provides affordable whole genome sequencing and AI-driven analysis to identify genetic predispositions, health risks, and personalized wellness strategies. This approach empowers individuals to make informed health decisions based on their unique genetic profiles, addressing the lack of accessible personalized healthcare solutions.

```xml <problem> Many individuals lack access to affordable and comprehensive genetic testing, hindering their ability to understand their predispositions to certain diseases and make informed healthcare decisions. Traditional genetic testing methods can be expensive and may not provide a complete picture of an individual's genetic makeup. </problem> <solution> MaddieBio offers whole genome sequencing and AI-driven analysis to provide individuals with personalized insights into their genetic predispositions, health risks, and potential responses to medications. By analyzing a person's entire genome, MaddieBio identifies key biomarkers and disease risks, empowering individuals to make proactive decisions about their health and wellness. The company's AI systems analyze genetic data to provide actionable steps tailored to an individual's unique genetic profile, accessible through a user-friendly mobile app. MaddieBio aims to translate genetic findings into personalized health solutions, enabling better health outcomes through genetics-based, personalized care. </solution> <features> - Affordable whole genome sequencing testing to uncover genetic variants influencing health. - AI-powered analysis of genetic data to identify key biomarkers and disease risks. - Personalized health reports on genetic risks, carrier status, wellness traits, and nutrition. - User-friendly mobile app for viewing reports, tracking goals, and receiving AI-generated insights. - Integration of a Genomic Large Language Model (LLM) with advanced analytics and machine learning for research partners. </features> <target_audience> MaddieBio's primary customers are individuals seeking to understand their genetic predispositions and optimize their health through personalized insights, as well as researchers looking to leverage genomic data for drug discovery and personalized medicine. </target_audience> ```

What does Maddie BioGenetics do?

Where is Maddie BioGenetics located?

Maddie BioGenetics is based in San Diego, United States.

When was Maddie BioGenetics founded?

Maddie BioGenetics was founded in 2023.

Location

San Diego, United States

Founded

2023

Employees

4 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Maddie BioGenetics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

maddiebio.com 100+

Founded 2023 – San Diego, United States

Funding

No funding information available.

Team (<5)

No team information available.

Company Description

Problem

Many individuals lack access to affordable and comprehensive genetic testing, hindering their ability to understand their predispositions to certain diseases and make informed healthcare decisions. Traditional genetic testing methods can be expensive and may not provide a complete picture of an individual's genetic makeup.

Solution

MaddieBio offers whole genome sequencing and AI-driven analysis to provide individuals with personalized insights into their genetic predispositions, health risks, and potential responses to medications. By analyzing a person's entire genome, MaddieBio identifies key biomarkers and disease risks, empowering individuals to make proactive decisions about their health and wellness. The company's AI systems analyze genetic data to provide actionable steps tailored to an individual's unique genetic profile, accessible through a user-friendly mobile app. MaddieBio aims to translate genetic findings into personalized health solutions, enabling better health outcomes through genetics-based, personalized care.

Features

Affordable whole genome sequencing testing to uncover genetic variants influencing health.

AI-powered analysis of genetic data to identify key biomarkers and disease risks.

Personalized health reports on genetic risks, carrier status, wellness traits, and nutrition.

User-friendly mobile app for viewing reports, tracking goals, and receiving AI-generated insights.

Integration of a Genomic Large Language Model (LLM) with advanced analytics and machine learning for research partners.

Target Audience

MaddieBio's primary customers are individuals seeking to understand their genetic predispositions and optimize their health through personalized insights, as well as researchers looking to leverage genomic data for drug discovery and personalized medicine.